This is a discussion on Liver Cancer Surgery Benefits Patients With Multiple Tumors, Portal Hypertension within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; Hepatic resection of hepatocellular carcinoma (HCC) should not be contraindicated in patients with multiple tumors or portal hypertension (PHT), according ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
Hepatic resection of hepatocellular carcinoma (HCC) should not be contraindicated in patients with multiple tumors or portal hypertension (PHT), according to a report from Japan in the June issue of Gastroenterology.
Reuters Health Information More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Lapatinib Appears Safe in Patients With Breast Cancer | industry_news | Other Clinical Pharmacy News | 0 | 07-17-2008 01:52 PM |
| Elderly Patients With Osteoarthritis May Benefit From Joint Replacement Surgery | industry_news | Other Clinical Pharmacy News | 0 | 07-15-2008 06:24 PM |
| Bevacizumab Shows Significant Activity in Liver Cancer | industry_news | Other Clinical Pharmacy News | 0 | 07-10-2008 06:00 PM |
| Increased Hemorrhagic Stroke Risk Attenuates Atorvastatin Benefits | industry_news | Other Clinical Pharmacy News | 0 | 06-30-2008 03:01 PM |
| Thalomid approval for multiple myeloma | participant1 | Managed Care Issues for Oral Drugs | 1 | 02-21-2008 05:45 PM |